drugset / Trial / NCT04882618

Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.

NCT04882618

Phase 4 Unknown 50 enrolled TC Erciyes University
NaSingle-groupOpen-labelTreatment

Summary

Standard treatment of local or locally advanced prostate cancer is radical prostatectomy (RRP) surgery. During RRP in certain patients extended lymph node dissection (ELND) is recommended. to detect eligible patients for ELND some nomograms based on clinical factors of them is used. The Briganti nomogram is one of them. If the patient has 7% or more probability on Briganti nomogram, then ELND is recommended. But ELND is complicated surgical procedure and may cause labor lost and cost. It is aimed here to show whether the ICG based fluorescence imaging during laparoscopy may yield higher accuracy to detect metastatic LNs than the conventional ELND?

Timeline

Start
2019-11-08
Primary completion
2021-11-08
Completion
2021-11-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent Other